Source Code Name Case count Share of cases (%)
PURCH PURCH_ATC(H05BA01) calcitonin (salmon synthetic); nasal, parenteral 2713
OUTPAT OUTPAT_ICD10(E210) Primary hyperparathyroidism 2479
OUTPAT OUTPAT_ICD10(E2109) Other primary hyperparathyroidism 2400
INPAT INPAT_ICD10(E2109) Other primary hyperparathyroidism 1434
INPAT INPAT_ICD10(E210) Primary hyperparathyroidism 1088
OUTPAT OUTPAT_ICD10(E213) Hyperparathyroidism, unspecified 1061
PRIM_OUT PRIM_OUT_NOT_USED_ICD10(E210) Primary hyperparathyroidism. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! 1007
PURCH PURCH_ATC(H05BX01) cinacalcet; oral 814
PRIM_OUT PRIM_OUT_NOT_USED_ICD10(E213) Hyperparathyroidism, unspecified. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! 735
PRIM_OUT PRIM_OUT_NOT_USED_ICD10(E2109) Other primary hyperparathyroidism. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! 659
INPAT INPAT_ICD10(E213) Hyperparathyroidism, unspecified 532
OUTPAT OUTPAT_ICD10(E212) Other hyperparathyroidism 431
OUTPAT OUTPAT_ICD10(E211) Secondary hyperparathyroidism, not elsewhere classified 233
INPAT INPAT_ICD10(E212) Other hyperparathyroidism 190
PRIM_OUT PRIM_OUT_NOT_USED_ICD10(E212) Other hyperparathyroidism. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! 164
PURCH PURCH_ATC(H05BX02) paricalcitol; systemic 149
INPAT INPAT_ICD10(E211) Secondary hyperparathyroidism, not elsewhere classified 115
INPAT INPAT_ICD9(2520A) Hyperparathyroidism 95
INPAT INPAT_ICD8(25200) Diseases of parathyroid gland, Hyperparathyroidism 79
PRIM_OUT PRIM_OUT_NOT_USED_ICD10(E211) Secondary hyperparathyroidism, not elsewhere classified. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS! 47
DEATH DEATH_ICD10(E210) Primary hyperparathyroidism 11